A. Bockisch

2.2k total citations
98 papers, 1.5k citations indexed

About

A. Bockisch is a scholar working on Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, A. Bockisch has authored 98 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Endocrinology, Diabetes and Metabolism, 44 papers in Radiology, Nuclear Medicine and Imaging and 19 papers in Epidemiology. Recurrent topics in A. Bockisch's work include Thyroid Cancer Diagnosis and Treatment (50 papers), Medical Imaging Techniques and Applications (21 papers) and Radiopharmaceutical Chemistry and Applications (19 papers). A. Bockisch is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (50 papers), Medical Imaging Techniques and Applications (21 papers) and Radiopharmaceutical Chemistry and Applications (19 papers). A. Bockisch collaborates with scholars based in Germany, United States and Netherlands. A. Bockisch's co-authors include Walter Jentzen, Rainer Görges, Lutz S. Freudenberg, Gerald Antoch, Klaus Mann, James Nagarajah, H.-J. Biersack, Maciej Bogdan Maniecki, Onno E. Janßen and Thomas Först and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Neurology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

A. Bockisch

95 papers receiving 1.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
A. Bockisch 843 643 400 267 205 98 1.5k
Michele Klain 1.4k 1.6× 451 0.7× 733 1.8× 261 1.0× 273 1.3× 97 2.1k
K Ikekubo 1.1k 1.3× 529 0.8× 292 0.7× 314 1.2× 163 0.8× 94 2.1k
Jennifer A. Sipos 1.3k 1.6× 211 0.3× 672 1.7× 171 0.6× 262 1.3× 50 1.8k
Ingo Brink 555 0.7× 812 1.3× 749 1.9× 470 1.8× 478 2.3× 58 2.3k
Zhong‐Ling Qiu 747 0.9× 275 0.4× 318 0.8× 134 0.5× 299 1.5× 70 1.3k
Harald Lahner 514 0.6× 162 0.3× 240 0.6× 555 2.1× 489 2.4× 69 1.5k
Min Ren 392 0.5× 309 0.5× 170 0.4× 216 0.8× 406 2.0× 80 1.7k
Angela Spanu 182 0.2× 676 1.1× 207 0.5× 145 0.5× 298 1.5× 104 1.3k
Marco Attard 1.7k 2.0× 219 0.3× 998 2.5× 248 0.9× 202 1.0× 28 2.0k
Giovanni Storto 186 0.2× 553 0.9× 292 0.7× 73 0.3× 225 1.1× 76 1.3k

Countries citing papers authored by A. Bockisch

Since Specialization
Citations

This map shows the geographic impact of A. Bockisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Bockisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Bockisch more than expected).

Fields of papers citing papers by A. Bockisch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Bockisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Bockisch. The network helps show where A. Bockisch may publish in the future.

Co-authorship network of co-authors of A. Bockisch

This figure shows the co-authorship network connecting the top 25 collaborators of A. Bockisch. A scholar is included among the top collaborators of A. Bockisch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Bockisch. A. Bockisch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kersting, David, Christoph Rischpler, Walter Jentzen, et al.. (2022). Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancer With MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study. Nuklearmedizin - NuclearMedicine. 61(2). 138–138. 4 indexed citations
2.
Ruhlmann, Marcus, et al.. (2016). Initiale [18F]FDG-PET/CT bei Hochrisikopatienten mit differenziertem Schilddrüsenkarzinom. Nuklearmedizin - NuclearMedicine. 55(3). 99–103. 5 indexed citations
3.
Jentzen, Walter, et al.. (2015). Niedrigste effektive Radioiodaktivität zur Ablation des Schilddrüsenrestes bei Patienten mit differenziertem Schilddrüsenkarzinom. Nuklearmedizin - NuclearMedicine. 54(3). 137–143. 9 indexed citations
4.
Binse, Ina, Thorsten D. Poeppel, Marcus Ruhlmann, et al.. (2015). Imaging with 124I in differentiated thyroid carcinoma: is PET/MRI superior to PET/CT?. European Journal of Nuclear Medicine and Molecular Imaging. 43(6). 1011–1017. 22 indexed citations
5.
Ruhlmann, Marcus, et al.. (2014). Diagnostik hyperfunktioneller Schilddrüsenknoten. Nuklearmedizin - NuclearMedicine. 53(5). 173–177. 9 indexed citations
6.
Nagarajah, James, et al.. (2012). 18F-Fluorid-PET/CT in der Skelettdiagnostik – Rolle der Schwächungskorrektur. Nuklearmedizin - NuclearMedicine. 51(3). 84–87. 5 indexed citations
7.
Nagarajah, James, et al.. (2012). 124I-PET/CT-Bildgebung bei Patienten mit Schilddrüsenkarzinomen – Unterscheidung zwischen Schilddrüsenrest und Lymphknotenmetastasen durch kinetische Größen. Nuklearmedizin - NuclearMedicine. 51(6). 213–216. 8 indexed citations
8.
Hartung, Verena, et al.. (2012). 18F-fluoride PET/CT for bone scanning. Nuklearmedizin - NuclearMedicine. 51(3). 84–87. 6 indexed citations
9.
Zimny, Michael, R. Pink, H. Palmedo, et al.. (2011). Szintigraphisch mehranreichernde Schilddrüsenknoten gehen überwiegend mit normwertigem TSH einher. Nuklearmedizin - NuclearMedicine. 50(5). 179–188. 22 indexed citations
10.
Kotzerke, J., Markus Dietlein, F. Grünwald, & A. Bockisch. (2010). Vorbehalte der DGN zur Nutzenbewertung der PET durch das IQWiG. Nuklearmedizin - NuclearMedicine. 49(1). 6–12. 7 indexed citations
11.
Petersenn, Stephan, Wieland Voigt, Thomas Kegel, et al.. (2009). Chemotherapy with Paclitaxel and Gemcitabine in Progressive Medullary and Thyroid Carcinoma of the Follicular Epithelium. Hormone and Metabolic Research. 42(1). 61–64. 12 indexed citations
12.
Petersenn, Stephan, et al.. (2008). Chemotherapy with Doxorubicin in Progressive Medullary and Thyroid Carcinoma of the Follicular Epithelium. Hormone and Metabolic Research. 40(3). 210–213. 59 indexed citations
13.
Freudenberg, Lutz S., Gerald Antoch, Andrea Frilling, et al.. (2008). Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET. European Journal of Nuclear Medicine and Molecular Imaging. 35(5). 950–957. 42 indexed citations
14.
Leischik, Roman, et al.. (2008). Vergleich von Belastungsechokardiographie und Radionuklidventrikulographie in der Diagnostik der Kardiomyopathie bei Patienten mit malignen Erkrankungen unter Chemotherapie. DMW - Deutsche Medizinische Wochenschrift. 122(49). 1509–1515. 2 indexed citations
15.
Heusner, Till A., et al.. (2007). Effekt verschiedener Chemoembolisationsmaterialien auf die CT-basierte Schwächungskorrektur der PET/CT. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 179(11). 1159–1165. 5 indexed citations
16.
Görges, Rainer, Bernhard Saller, E. G. Eising, et al.. (2002). Surveillance of TSH-Suppressive Levothyroxine Treatment in Thyroid Cancer Patients: TRH Testing Versus Basal TSH Determination by a Third Generation Assay. Experimental and Clinical Endocrinology & Diabetes. 110(7). 355–360. 1 indexed citations
17.
Kopf, Daniel, et al.. (2001). A double-blind trial of perindopril and nitrendipine in incipient diabetic nephropathy.. PubMed. 14(5). 245–52. 7 indexed citations
18.
Schlösser, Ralf G.M., S. Schlegel, Christoph Hiemke, et al.. (1997). [123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects. Psychiatry Research Neuroimaging. 75(2). 103–114. 11 indexed citations
19.
Först, Thomas, J. Beyer, A Pfützner, et al.. (1995). Peripheral Osteopenia in Adult Patients with Insulin‐dependent Diabetes Mellitus. Diabetic Medicine. 12(10). 874–879. 80 indexed citations
20.
Kreft, Burkhard, et al.. (1990). Qualitative und quantitative kernspintomographische Befunde der fokal nodulären Hyperplasie der Leber. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 152(6). 649–653. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michele Klain Breakdown of academic impact, for papers by K Ikekubo Breakdown of academic impact, for papers by Jennifer A. Sipos Breakdown of academic impact, for papers by Ingo Brink Breakdown of academic impact, for papers by Zhong‐Ling Qiu Breakdown of academic impact, for papers by Harald Lahner Breakdown of academic impact, for papers by Min Ren Breakdown of academic impact, for papers by Angela Spanu Breakdown of academic impact, for papers by Marco Attard Breakdown of academic impact, for papers by Giovanni Storto
Rankless by CCL
2026